RP Analyses of Monoclonal Antibodies Using High Temperatures

27 Jun 2019

In this application note, YMC illustrates how to achieve robust chromatographic results for two commercially available MAbs: Adalimumab (e.g. Humira®) and Bevacizumab (Avastin®) with the YMC-Triart Bio C4.

Links

Tags